Apolipoprotein E Polymorphism in 385 Patients on Renal Replacement Therapy in Sweden

References

• Mahley RW, Innerarity TL, Rail DC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984; 25: 1227–94.
   Web of Science ®Google Scholar
• Rail SC, Weigraber KH, Mahley RW. Human apolipo-protein E: the complete amino acid sequence. J Biol Chem 1982; 257: 4171–8.
   Google Scholar
• Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipopro-teinaemia in man. Nature 1977; 269: 604–7.
   Google Scholar
• Zannis VI, Breslow JL. Human very low-density lipo-protein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 1981; 20: 1033–41.
   PubMed Web of Science ®Google Scholar
• Zannis VI, Breslow It, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, et al. Proposed nomenclature of apo E isoproteins, apo E genotypes and phenotypes. J Lipid Res 1982; 23: 911–4.
   PubMed Web of Science ®Google Scholar
• Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268–85.
   PubMed Web of Science ®Google Scholar
• Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The role of apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and trigly-cerides in a sample of unrelated individuals. Am J Med Genet 1987; 27: 567–82.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P. Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal disease [Review]. Lancet 2001; 357: 1601–8.
   Google Scholar
• Feussner G, Wey S, Bommer J, Deppermann D, Grutzmacher P, Ziegler R. Apolipoprotein E pheno-types and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet 1992; 88: 307–12.
   PubMed Web of Science ®Google Scholar
• Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein abnormalities in hyperlipi-demic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 1992; 41: 1394–9.
   Google Scholar
• Oda H, Yorioka N, Ueda C, Kushihata S, Yamakido M. Apolipoprotein E polymorphism and renal disease. Kidney Int 1999; Suppl 71: S25–7.
   Google Scholar
• Eggertsen G, HeimbUrger 0, Stenvinkel P. Berglund L. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Nephrol Dial Transplant 1997; 12: 141–4.
   Google Scholar
• Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39: 2125–9.
   Google Scholar
• Roussos L, Floren C-H, Carlson J, Svensson PJ, Wall-mark A, Ekberg H. Increased frequency of apolipopro-tein E3/E4 genotype among Swedish renal transplant recipients. Nephron 1999; 83: 25–30.
   Google Scholar
• Henriksson KM, Lindblad U, Gullberg B, Agren B, Nilsson-Ehle P, Rastam L. Development of hypertension over 6 years in a birth cohort of young middle-aged men: the Cardiovascular Risk Factor Study in southern Sweden (CRISS). J Intern Med 2002; 252: 21–6.
   Google Scholar
• Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545–8.
   PubMed Web of Science ®Google Scholar
• Mitch WE, Walser M. A simple method of estimating progression of chronic renal failure. Lancet 1976; ii: 1326–7.
   Google Scholar
• Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int 1977; 11: 62–70.
   Google Scholar
• Laakso M, Kesdniemi A, Kervinen K, Jauhiainen M, Pyorala K. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. Br Med J 1991; 303: 1159–62.
   Google Scholar
• Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 1998; 31: 666–73.
   PubMed Web of Science ®Google Scholar
• Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, et al. Apolipoprotein E genetic polymorph-ism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 2002; 40: 243–51.
   PubMed Web of Science ®Google Scholar
• Davis ID, MacRae Dell K, Sweeny WE, Avner ED. Can progression of autosomal dominant or recessive poly-cystic kidney disease be prevented? Semin Nephrol 2001; 21: 430–40.
   PubMed Web of Science ®Google Scholar
• Dijk van MA, Kamper AM, Veen van S, Souverijn JH, Blauw GJ. Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2001; 16: 2152–7.
   PubMed Web of Science ®Google Scholar
• Davignon J, Bouthikier D, Nestruck AC, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenerians. Trans Am Clin Climatol Assoc 1987; 99: 100–10.
   Google Scholar
• Gabow PA. Cystic diseases of the kidney. In: Morgan SH, Griinfeld JP, eds. Inherited disorders of the kidney. Oxford, UK: Oxford University Press; 1998: 132–62.
   Google Scholar
• Peters DLM, Breuning MH. Autosomal dominant poly-cystic kidney disease: modification of disease progres-sion. Lancet 2001; 358: 1439–44.
   PubMed Web of Science ®Google Scholar
• Wilson PW, Myers RH, Larson MG, Ordovas IM, Wolf PA, Schaefer EJ. Apolipoprotein e alleles, dyslipidemia, and coronary heart disease. The Framingham offspring study. JAMA 1994; 272: 1666–71.
   Google Scholar
• Wang XL, McCredie RM, Wilcken DEL. Polymorph-isms of the apolipoprotein e gene and severity of coronary artery disease defined by angiography. Arterio-scler Thromb 1995; 15: 1030–4.
   Google Scholar
• Vauhkonen I, Niskanen L, Ryynanen M, Voutilainen R, Partanen J, Toyry J, et al. Divergent association of apo-lipoprotein e polymorphism with vascular disease in patients with NIDDM and control subjects. Diabetic Med 1997; 14: 748–56.
   PubMed Web of Science ®Google Scholar
• Lim PS, Liu CS, Hong CJ, Wei YH. Prevalence of apolipoprotein e genotypes in ischaemic cerebovascular disease in end-stage renal disease patients. Nephrol Dial Transplant 1997; 12: 1916–20.
   PubMed Web of Science ®Google Scholar
• Freely associating [editorial]. Nat Genet 1999; 22: 1–2.
   PubMed Web of Science ®Google Scholar